Zealand Pharma’s drug for rare metabolic disease smashes phase III
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
20/05/2022 - 4 minutes
Jon Smith
Reporter for Labiotech. I hail from the UK. I was born in Bristol, studied Neuroscience in the University of Bristol, and trained mice in Eisai, Hertfordshire, for one year. I then tickled locusts for my Ph.D. at the University of Leicester, before eventually ending up here!
Out of the office, I travel, play video games and board games, drink beer and play the piano.
Valneva’s Covid-19 Vaccine Contract in Dire Straits as EU Approval Lags
The stock price of the French Covid-19 vaccine maker Valneva has been knocked down by…
16/05/2022 - 3 minutes
The Top European Biotech Investments in April 2022
Private biotech investments in Europe were on a steady decline in April 2022 as biotech…
12/05/2022 - 4 minutes
eureKARE Launches €150M Merger to Form Cell and Gene Therapy CDMO
The French startup creator eureKARE has set up a special purposes acquisition company (SPAC) with…
10/05/2022 - 4 minutes
Amphista Lands Megadeals to Smash Cancer using Protein Degradation
As big pharma companies flock to drugs that destroy harmful proteins, the UK protein degradation…
05/05/2022 - 3 minutes
Tubulis Rides Investment Wave in ADCs with €60M Series B
The German firm Tubulis has raised a €60M Series B round to advance cancer drugs…
03/05/2022 - 3 minutes
Denmark Recruits Lifebit to Boost Personalized Medicine with Genomics
The Danish National Genome Center has teamed up with the UK firm Lifebit to improve…
29/04/2022 - 3 minutes
OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B
The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll…
28/04/2022 - 3 minutes
Cancer Research UK Deploys €700M to Foster Oncology Startups
In a show of strength after an income squeeze during the Covid-19 pandemic, the charity…
27/04/2022 - 4 minutes
Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs
The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from…
25/04/2022 - 4 minutes
European Biotech Investors Brace for Volatility in 2022
After gathering huge investment funds in 2021, European biotech investors took a breather in the…
22/04/2022 - 4 minutes
Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights
A Covid-19 vaccine developed by the French company Valneva has received the green light from…
20/04/2022 - 4 minutes
